Crescent Biopharma Inc
F:C68
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Crescent Biopharma Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Crescent Biopharma Does
Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company is headquartered in Waltham, Massachusetts and currently employs 4 full-time employees. The company went IPO on 2014-01-10. The firm is focused on advancing the next wave of therapies for cancer patients. The Company’s pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates.
- Headquarters
- United States of America US
- Employees
- 4
- IPO date
- Jan 10, 2014
Balance Sheet
Continue C68 Research
Decided on Crescent Biopharma? Get an email when C68 reaches the price you’d buy at. Free with an account.